In severe disease of the aortic valve, choosing a new heart valve is especially difficult for young women who want to become pregnant.

The Transcatheter Tricuspid Valve Replacement market expands as Laplace launches its 400-patient pivotal study.

JenaValve today announced new clinical findings for its Trilogy TAVR system shared last week at the New York Valves 2026 ...

New Evidence Further Defines Distinct Clinical Considerations for Transcatheter Aortic Valve Replacement (TAVR) in Aortic Regurgitation (AR) and ...

Researchers at UNSW Sydney have developed a fully synthetic soft robotic heart that reproduces the complex movements and ...

Flowserve Corporation (NYSE: FLS) (“Flowserve” or the “Company”), a leading provider of flow control products and services for the global infrastructure markets, has closed its all-cash acquisition of ...

Hejian Honglun Hydraulic Parts Co., Ltd. (HL FLUID), a leading Chinese manufacturer of hydraulic and pneumatic quick coupling systems since 2010, has officially introduced its latest innovation—the ...

The global bovine pericardial valve market is entering a transformative phase as healthcare systems increasingly align ...

International groups agreed on a second universal definition of heart failure, which moves away from rigid ejection fraction ...

Pneumatic valve selection is often treated as a component-sizing exercise, with datasheet-based specifications. Once pressure ...

Edwards Lifesciences secures FDA clearance for its ECLIPTIS Left Atrial Appendage Exclusion System, entering a competitive ...

The FDA cleared EchoNext, the first artificial intelligence tool to detect structural heart disease before symptoms present.